NCT02221141View on ClinicalTrials.gov

Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
Left Ventricular Hypertrophy
Trial Locations (1)

5530

CHU Dinant-Godinne, Yvoir

All Listed Sponsors
lead

Laurence Gabriel

OTHER

NCT02221141 - Screening of Fabry Disease in Patients With Left Ventricular Hypertrophy Detected in Echocardiography | Biotech Hunter | Biotech Hunter